Clinical Trial

Lorlatinib Renal Impairment Study

Study Description

Lorlatinib Renal Impairment Study

This is a Phase 1, open-label, multi-center, single treatment study in subjects with normal renal function and varying degrees of renal impairment.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Lorlatinib

Lorlatinib single oral dose

Additional Information

Official Study Title

A PHASE 1, SINGLE DOSE OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS OF LORLATINIB IN SUBJECTS WITH IMPAIRED RENAL FUNCTION

Clinical Trial ID

NCT03542305

ParticipAid ID

QeZlQb